Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

1.

Re-expression of sonic hedgehog and reduction of CDX2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia.

Shiotani A, Uedo N, Iishi H, Tatsuta M, Ishiguro S, Nakae Y, Kamada T, Haruma K, Merchant JL.

Int J Cancer. 2007 Sep 15;121(6):1182-9.

2.

Helicobacter pylori-induced atrophic gastritis progressing to gastric cancer exhibits sonic hedgehog loss and aberrant CDX2 expression.

Shiotani A, Iishi H, Uedo N, Ishihara R, Ishiguro S, Tatsuta M, Nakae Y, Kumamoto M, Hinoi T, Merchant JL.

Aliment Pharmacol Ther. 2006 Dec;24 Suppl 4:71-80.

3.

Sonic hedgehog and CDX2 expression in the stomach.

Shiotani A, Kamada T, Yamanaka Y, Manabe N, Kusunoki H, Hata J, Haruma K.

J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S161-6. doi: 10.1111/j.1440-1746.2008.05406.x. Review.

PMID:
19120891
4.
5.

Helicobacter pylori infection induces a reversible expression of the CDX2 transcription factor protein in human gastric epithelium.

Vauhkonen M, Vauhkonen H, Sipponen P.

Scand J Gastroenterol. 2008 Aug;43(8):915-21.

PMID:
19086163
6.

Helicobacter pylori eradication prevents extension of intestinalization even in the high-risk group for gastric cancer.

Shiotani A, Nishi R, Uedo N, Iishi H, Tsutsui H, Ishii M, Imamura H, Kamada T, Hata J, Haruma K.

Digestion. 2010;81(4):223-30. doi: 10.1159/000264651. Epub 2010 Jan 29.

PMID:
20110706
7.

[Effect of Helicobacter pylori infection and eradication on proliferative kinetics of the gastric mucosa].

Unger Z, Prónai L, Szaleczky E, Zágoni T, Molnár B, Tulassay Z.

Orv Hetil. 2000 Dec 10;141(50):2695-700. Hungarian.

PMID:
11189675
8.

Aberrant expression of CDX2 in the gastric mucosa with and without intestinal metaplasia: effect of eradication of Helicobacter pylori.

Satoh K, Mutoh H, Eda A, Yanaka I, Osawa H, Honda S, Kawata H, Kihira K, Sugano K.

Helicobacter. 2002 Jun;7(3):192-8.

PMID:
12047325
9.

H. pylori eradication did not improve dysregulation of specific oncogenic miRNAs in intestinal metaplastic glands.

Shiotani A, Uedo N, Iishi H, Murao T, Kanzaki T, Kimura Y, Kamada T, Kusunoki H, Inoue K, Haruma K.

J Gastroenterol. 2012 Sep;47(9):988-98. doi: 10.1007/s00535-012-0562-7. Epub 2012 Mar 1.

PMID:
22382634
10.

Evidence that loss of sonic hedgehog is an indicator of Helicobater pylori-induced atrophic gastritis progressing to gastric cancer.

Shiotani A, Iishi H, Uedo N, Ishiguro S, Tatsuta M, Nakae Y, Kumamoto M, Merchant JL.

Am J Gastroenterol. 2005 Mar;100(3):581-7.

PMID:
15743355
11.

Celecoxib inhibits Cdx2 expression and prevents gastric cancer in Helicobacter pylori-infected Mongolian gerbils.

Futagami S, Suzuki K, Hiratsuka T, Shindo T, Hamamoto T, Tatsuguchi A, Ueki N, Shinji Y, Kusunoki M, Wada K, Miyake K, Gudis K, Tsukui T, Sakamoto C.

Digestion. 2006;74(3-4):187-98. Epub 2007 Mar 6.

PMID:
17341852
12.

Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis.

Ito M, Haruma K, Kamada T, Mihara M, Kim S, Kitadai Y, Sumii M, Tanaka S, Yoshihara M, Chayama K.

Aliment Pharmacol Ther. 2002 Aug;16(8):1449-56.

13.

Effect of Helicobacter pylori eradication on gastric epithelial proliferation. Relationship with ras oncogene p21 expression.

Ierardi E, Francavilla A, Balzano T, Traversa A, Principi M, Monno RA, Amoruso A, Ingrosso M, Pisani A, Panella C.

Ital J Gastroenterol Hepatol. 1997 Jun;29(3):214-9.

PMID:
9646212
14.

Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.

Maconi G, Lazzaroni M, Sangaletti O, Bargiggia S, Vago L, Bianchi Porro G.

Am J Gastroenterol. 1997 Oct;92(10):1844-8.

PMID:
9382049
15.

Follow-Up Study on CDX1 and CDX2 mRNA Expression in Noncancerous Gastric Mucosae After Helicobacter pylori Eradication.

Shin CM, Kim N, Chang H, Kim JS, Lee DH, Jung HC.

Dig Dis Sci. 2016 Apr;61(4):1051-9. doi: 10.1007/s10620-016-4048-y. Epub 2016 Feb 3.

PMID:
26841784
16.

Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas.

Arista-Nasr J, Jiménez-Rosas F, Uribe-Uribe N, Herrera-Goepfert R, Lazos-Ochoa M.

Am J Gastroenterol. 2001 Jun;96(6):1746-50.

PMID:
11419824
18.

Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.

Liu KS, Wong IO, Leung WK.

World J Gastroenterol. 2016 Jan 21;22(3):1311-20. doi: 10.3748/wjg.v22.i3.1311. Review.

19.

Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.

Leung WK, Lin SR, Ching JY, To KF, Ng EK, Chan FK, Lau JY, Sung JJ.

Gut. 2004 Sep;53(9):1244-9.

20.

Helicobacter pylori induces gastric mucosal intestinal metaplasia through the inhibition of interleukin-4-mediated HMG box protein Sox2 expression.

Asonuma S, Imatani A, Asano N, Oikawa T, Konishi H, Iijima K, Koike T, Ohara S, Shimosegawa T.

Am J Physiol Gastrointest Liver Physiol. 2009 Aug;297(2):G312-22. doi: 10.1152/ajpgi.00518.2007. Epub 2009 Jun 11.

Supplemental Content

Support Center